Predictors of severity and mortality in COVID-19 patients
Tóm tắt
Từ khóa
Tài liệu tham khảo
Pandita A, Gillani FS, Shi Y, Hardesty A, McCarthy M, Aridi J et al (2021) Predictors of severity and mortality among patients hospitalized with COVID-19 in Rhode Island. PLoS One 16(6):e0252411
Malik P, Patel U, Mehta D, Patel N, Kelkar R, Akrmah M et al (2021) Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evid Based Med 26(3):107–108
Elshazli RM, Toraih EA, Elgaml A, El-Mowafy M, El-Mesery M, Amin M et al (2020) Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: a meta-analysis of 6320 patients. PLoS One 15:e0238160
Stringer D, Braude P, Myint PK, Evans L, Collins JT, Verduri A et al (2021) The role of C-reactive protein as a prognostic marker in COVID-19. Int J Epidemiol 50(2):420–429
Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z et al (2020) d-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care 2020:49
Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH et al (2020) Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis. J Med Virol 92(10):1875–1883
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054–1062
Yu H, Qin C, Chen M, Wang W, Tian D (2020) d-dimer level is associated with the severity of COVID-19. Thromb Res 195:219–225
Yuan J, Zou R, Zeng L, Kou S, Lan J, Li X et al (2020) The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients. Inflamm Res 69(6):599-606
Zhao K, Li R, Wu X, Zhao Y, Wang T, Zheng Z et al (2020) Clinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysis. Eur J Clin Microbiol Infect Dis 39(12):2279–2287
Vasdev S, Stuckless J, Richardson V (2011) Role of the immune system in hypertension: modulation by dietary antioxidants. Int J Angiol 20(04):189–212
Ferlita S, Yegiazaryan A, Noori N, Lal G, Nguyen T, To K et al (2019) Type 2 diabetes mellitus and altered immune system leading to susceptibility to pathogens, especially Mycobacterium tuberculosis. J Clin Med 8(12):2219
Hermann M, Flammer A, Luscher TF (2006) Nitric oxide in hypertension. J Clin Hypertens 8(12 Suppl 4):17–29
Honing ML, Morrison PJ, Banga JD, Stroes ES, Rabelink TJ (1998) Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev 14(3):241–249
Marrazzo F, Spina S, Zadek F, Lama T, Xu C, Larson G et al (2019) Protocol of a randomised controlled trial in cardiac surgical patients with endothelial dysfunction aimed to prevent postoperative acute kidney injury by administering nitric oxide gas. BMJ Open 9(7):e026848
Henry BM, Lippi G (2020) Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol 52(6):1193–1194
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L et al (2020) Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97(5):829–838
Arnold FW, Fuqua JL (2020) Viral respiratory infections: a cause of community acquired pneumonia or a predisposing factor? Curr Opin Pulm Med 26(3):208–214
Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J et al (2020) Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol 127:104364
Kim D, Quinn J, Pinsky B, Shah NH, Brown I (2020) Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA 323:2085–2086
Contou D, Claudinon A, Pajot O, Micaëlo M, Flandre PL, Dubert M et al (2020) Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann Intensive Care 10:119
Musuuza JS, Watson L, Parmasad V, Putman-Buehler N, Christensen L, Safdar N (2021) Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis. PLoS One 16(5):e0251170
Manal M, Mohammed AA, Abdelilah E, Mohammed M, Khaoula J, Houssam B et al (2021) Predictive factors of mortality related to COVID-19: a retrospective cohort study of 600 cases in the intensive care unit of the university hospital of Oujda. Ann Med Surg 69:102711
Vafea MT, Zhang R, Kalligeros M, Mylona EK, Shehadeh F, Mylonakis E (2021) Mortality in mechanically ventilated patients with COVID-19: a systematic review. Expert Rev Med Devices. https://doi.org/10.1080/17434440.2021.1915764
Feinstein MM, Niforatos JD, Hyun I, Cunningham TV, Reynolds A, Brodie D et al (2020) Considerations for ventilator triage during the COVID-19 pandemic. Lancet Respir Med 8(6):e53
Riccioni L, Bertolini G, Giannini A, Vergano M, Gristina G, Livigni S et al (2020) Clinical ethics recommendations for the allocation of intensive care treatments, in exceptional, resource-limited circumstances. Recenti Prog Med 111(4):207–211
Wang Y, Lu X, Li Y, Chen H, Chen T, Su N et al (2020) Clinical course and outcomes of 344 intensive care patients with COVID-19. Am J Respir Crit Care Med 201(11):1430–1434
Xu J, Yang X, Yang L, Zou X, Wang Y, Wu Y et al (2020) Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China. Crit Care 24(1):394
Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, Hernandez M, Gea A, Arruti E et al (2020) Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med 46(12):2200–2211
Gupta S, Hayek SS, Wang W, Chan L, Mathews K, Melamed M et al (2020) Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med 180(11):1436–1447